Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Masataka Ogiso"'
Autor:
Masataka Ogiso, MD, Atsushi Suzuki, MD, Tsuyoshi Shiga, MD, Kenji Nakai, MD, Morio Shoda, MD, Nobuhisa Hagiwara, MD
Publikováno v:
Journal of Arrhythmia, Vol 31, Iss 1, Pp 1-5 (2015)
Background: The effect of intravenous amiodarone on spatial and transmural dispersion of ventricular repolarization in patients receiving cardiac resynchronization therapy (CRT) remains unclear. Methods: We studied 14 patients with nonischemic heart
Externí odkaz:
https://doaj.org/article/9978cb1547174acaa0bb202a4d108381
Autor:
Morio Shoda, Masataka Ogiso, Hisashi Sugiyama, Nobuhisa Hagiwara, Hirotaka Ohki, Ken Kato, Hiroyuki Tanaka, Koichiro Ejima, Masaru Miura
Publikováno v:
Journal of Cardiovascular Electrophysiology. 32:279-286
Introduction Given that few studies investigated the efficacy of catheter ablation (CA) in patients with paroxysmal atrial fibrillation (AF) and atrial septal defect (ASD), this study evaluated its effectiveness in patients with paroxysmal AF and ASD
Publikováno v:
Congenital Heart Disease. 15:483-493
Autor:
Erisa Kawada-Watanabe, Masataka Ogiso, Nobuo Iguchi, Yoshimi Ota, Nobuhisa Hagiwara, Shinya Fujii, Haruki Sekiguchi, Hiroshi Ogawa, Ryo Koyanagi, Junichi Yamaguchi, Tomohiro Sakamoto, Hisayuki Okada, Hiroyuki Tanaka, Kentaro Jujo
Publikováno v:
Circulation Reports
Background: The effects of aggressive lipid-lowering therapy according to the number of diseased coronary arteries in acute coronary syndrome (ACS) are still controversial. This study investigated the efficacy of this therapy in ACS patients with mul
Autor:
Haruki Sekiguchi, Masataka Ogiso, Hiroyuki Arashi, Junichi Yamaguchi, Nobuhisa Hagiwara, Hisao Otsuki, Hiroshi Ogawa
Publikováno v:
Heart and vessels. 36(11)
Despite a clear correlation between anemia and mortality in patients with the acute coronary syndrome (ACS), anemia as a mortality predictor in patients with ACS-receiving early invasive strategy and contemporary lipid-lowering therapy has not been e
Publikováno v:
Heart and Vessels. 33:1576-1583
Cardiac involvement in muscular dystrophy (MD) is known to cause heart failure (HF). However, little is known about the differences in electrocardiographic and echocardiographic findings between MD patients with and without the experience of hospital
Autor:
Ai Masukawa, Chihiro Takuwa-Shiomi, Hiroshi Niinami, Toshiaki Isogai, Nobuhisa Hagiwara, Ken Kato, Takahiro Kiriu, Masataka Ogiso, Hiroyuki Tanaka
Peripartum cardiomyopathy (PPCM) is a rare disorder in which left ventricular (LV) systolic dysfunction and symptoms of heart failure (HF) occur in the peripartum period. The time to potential recovery from severe remodeling of ventricular function i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5ac7bde644ab4571c5fa1eb011a5a7
https://europepmc.org/articles/PMC6951448/
https://europepmc.org/articles/PMC6951448/
Publikováno v:
Internal Medicine. 54:801-804
A 60-year-old woman presented with ST-elevation myocardial infarction due to extrinsic compression of the left main coronary artery (LMCA) caused by a dilated pulmonary artery (PA) with idiopathic pulmonary hypertension and was successfully treated w
Publikováno v:
Heart and vessels. 32(8)
Although a previous randomized study showed that the use of atrial natriuretic peptide (carperitide) improved the long-term prognosis of patients with heart failure, its effect on short-term prognosis remains unclear. We retrospectively identified pa
Autor:
Haruki Sekiguchi, Erisa Watanabe, Junichi Yamaguchi, Hiroyuki Arashi, Risa Ogawa, Masataka Ogiso, Hiroshi Ogawa, Nobuhisa Hagiwara
Publikováno v:
Journal of the American College of Cardiology. 71:A53
Few reports elucidate the impact of high sensitivity C reactive protein (hsCRP) level on clinical outcomes in acute coronary syndrome (ACS) patients with dyslipidemia undergoing contemporary pharmacotherapy. We examined the effect of hsCRP in chronic